The bisphosphonate zoledronate prevents vertebral bone loss in mature estrogen-deficient rats as assessed by micro-computed tomography

European Cells and Materials

Volumn 1, Issue , 2001, Pages 18-26

  Glatt, Markus ^a   Daculsi, G ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b WKL 125902 ^*

Author keywords

Bisphosphonate; Bone; Bone architecture; Estrogen deficiency; Microcomputed tomography; Morphometry; Ovariectomy; Rat; Vertebrae; Zoledronate

Indexed keywords

BISPHOSPHONATE ZOLEDRONATE; BISPHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE STRUCTURE; CANCELLOUS BONE; CELL ACTIVITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ESTROGEN DEFICIENCY; FEMALE; LONG TERM CARE; MORPHOMETRICS; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; OVARIECTOMY; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; TRABECULAR BONE; TREATMENT OUTCOME; VERTEBRA; VERTEBRA BODY;

EID: 0002074991     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v001a03     Document Type: Article

References (43)

1. Abe T, Sato K, Miyakoshi N, Kudo T, Tamura Y, Tsuchida T, Kasukawa Y (1999) Trabecular remodeling processes in the ovariectomized rat: Modified node-strut analysis. Bone 24: 591-596.
2. Acito AJ, Kasra M, Lee JM, Grynpas MD (1994) Effects of intermittent administration of pamidronate on the mechanical properties of canine cortical and trabecular bone. J Orthop Res 12: 742-746.
3. Aerssens J, Boonen S, Lowet G, Dequeker J (1998) Interspecies differences in bone composition, density, and quality: potential implications for in vivo bone research. Endocrinology 139: 663-670.
4. Amling M, Pösl M, Ritzel H, Hahn M, Vogel M, Wening VJ, Delling G (1996) Architecture and distribution of cancellous bone yield vertebral fracture clues. Arch Orthop Trauma Surg 115: 262-269.
5. Bagi CM, Mecham M, Weiss J, Miller SC (1993) Comparative morphometric changes in rat cortical bone following ovariectomy and/or immobilization. Bone 14: 877-883
6. Delling G, Hahn M, Bonse U, Busch F, Günnewig O, Beckmann F, Uebbing H, Graeff W (1995) New applications of structure analysis of bone biopsies in microcomputed tomography. Pathologe 16: 342-347.
7. Dempster DW, Birchman R, Xu R, Lindsay R, and Shen V (1995) Temporal changes in cancellous bone structure of rats immediately after ovariectomy. Bone 16: 157-161.
8. Fleisch H (1991) Bisphosphonates. Pharmacology and use in the treatment of tumor-induced hypercal-caemic and metastatic bone disease. Drugs 42: 919-944.
9. Frost HM, Jee WSS (1992) On the rat model of human osteopenias and osteoporoses. Bone Mineral 18: 227-236.
10. Goulet RW, Goldstein SA, Ciarelli MJ, Kuhn JL, Brown MB, Feldkamp LA (1994) The relationship between the structural and orthogonal compressive properties of rabecular bone. J Biomechanics 27: 375-389.
11. Green JR, Müller K, Jaeggi K (1994) Preclinical pharmacology of CGP 42'446, a new, potent, hetero-cyclic bisphosphonate compound. J Bone Mineral Res 5: 745-751.
12. Green JR, Seltenmeyer Y, Jaeggi K, Widler L (1997) Renal tolerability profile of novel, potent bisphosphonates in two short-term rat models. Pharmacol Toxicol 80: 225-230.
13. Grynpas MD, Acito A, Dimitriu M, Mertz BP, Véry JM (1992) Changes in bone mineralization, architecture and mechanical properties due to long-term (1 year) administration of pamidronate (APD) to adult dogs. Osteoporosis Int 2: 74-81.
14. Hahn M, Vogel M, Pompesius-Kempa M, Delling G (1992) Trabecular bone pattern factor - a new parameter for simple quantification of bone micro-architecture. Bone 13: 327-330.
15. Haidekker MA, Andresen R, Werner HJ (1999) Relationship between structural parameters, bone mineral density and fracture load in lumbar vertebrae, based on high-resolution computed tomography, quanti-tative computed tomography and compression tests. Osteoporosis Int 9: 433-440.
16. Ito M, Nakamura T, Matsumoto T, Tsurusaki K, Hayashi K (1998) Analysis of trabecular micro-architecture of human iliac bone using microcomputed tomography in patients with hip arthrosis with or without vertebral fracture. Bone 23: 163-169.
17. Kalu DN (1991) The ovariectomized rat model of post-menopausal bone loss. Bone Mineral 15: 175-192.
18. Katsumata T, Nakamura T, Ohnishi H, Sakurama T (1995) Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized rats. J Bone Mineral Res 10: 921-931.
19. Kippo K, Hannuniemi R, Laurén L, Peng Z, Isaksson P, Virtamo T, Osterman T, Pasanen I, Sellman R, Väänänen R (1997) Clodronate prevents bone loss in aged ovariectomized rats. Calcif Tissue Int 61: 151-157.
20. Lafage MH, Balena R, Battle MA, Shea M, Seedor GJ, Klein H, Hayes W, Rodan G (1995) Comparison of alendronate and sodium fluoride effects on cancellous and cortical bone in minipigs. A one-year study. J Clin Invest 95: 2127-2133.
21. Lane J, Ralis ZA (1983) Changes in dimensions of large cancellous bone specimens during histological preparation as measured on slabs from human femoral heads. Calcif Tissue Int 35: 1-4.
22. Lane NE, Thompson JM, Haupt D, Kimmel D, Modin G, Kinney JH (1998) Acute changes in trabecular bone connectivity and osteoclast activity in the ovariectomized rat in vivo. J Bone Mineral Res 13: 229-236.
23. Lepola VT, Kippo K, Hannuniemi R, Laurén L, Virtamo T, Osterman T, Jalovaara P, Sellman R, Väänänen HK (1996) Bisphosphonates clodronate and etidronate in the prevention of ovariectomy-induced osteopenia in growing rats. J Bone Miner Res 11: 1508-1517.
24. 2 on production of new cancellous bone in the axial skeleton of ovariectomized rats. Bone 11: 103-113.
25. Mosekilde L, Danielsen CC, Knudsen UB (1993) The effect of aging and ovariectomy on the vertebral bone mass and biomechanical properties of mature rats. Bone 14: 1-6.
26. Motoie H, Nakamura T, O'Uchi N, Nishikawa H, Kanoh H, Abe T, Kawashima H (1995) Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction. J Bone Mineral Res 10: 910-920.
27. Müller R, van Campenhout H, van Damme, van der Perre G, Dequeker J, Hildebrand T, Rüegsegger P (1998) Morphometric analysis of human bone biopsies: A quantitative structural comparison of histological sections and micro-computed tomography. Bone 23: 59-66.
28. Papapoulos SE, Landman JO, Bijvoet OLM, Löwik CWGM, Valkema R, Pauwels EKJ, Vermeij P (1992) The use of bisphosphonates in the treatment of osteoporosis. Bone 13: S41-S49.
29. Pataki A, Müller K, Green J, Ma YF, Li QN, Jee WSS (1997) Effects of short term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: A comparative histomorphometric study on the cancellous bone formed before, during, and after treatment. Anatom Rec 249: 458-468.
30. Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M, Frame B, Rao DS (1983) Relationship between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. J Clin Invest 72: 1396-1409.
31. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker R (1987) Bone histomorphometry: Standardization of nomenclature, symbols and units. J Bone Mineral Res 2: 595-610.
32. Rodan GA (1998) Mechanisms of action of bisphosphonates. Ann Rev Pharmacol Toxicol 38: 375-388.
33. Romeis B (1989) Mikroskopische Technik (Microscopical Technique). Böck P, ed. Urban und Schwarzenberg, München. pp. 559-560.
34. Rüegsegger P, Koller B, Müller R (1996) A microtomographic system for the nondestructive evaluation of bone architecture. Calcif Tissue Int 58: 24-29.
35. Russell RGG, Rogers MJ (1999) Bisphosphonates: From the laboratory to the clinic and back again. Bone 25: 97-106.
36. Singer FR, Minoofar PN (1995) Bisphosphonates in the treatment of disorders of mineral metabolism. Adv Endocrinol Metab 6: 259-288.
37. Toolan BC, Shea M, Myers ER, Borchers RE, Seedor JG, Quartuccio H, Rodan G, Hayes WC (1992) Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats. J Bone Miner Res 7: 1399-1406.
38. Uchiyama T, Tanizawa T, Muramatsu H, Endo N, Takahashi HE, Hara T (1997) A morphometric com-parison of trabecular structure of human ilium between microcomputed tomography and conventional histo-morphometry. Calcif Tissue Int 61: 493-498.
39. Wronski TJ, Dann LM, Scott KS, and Cintron M (1989a) Long-term effects of ovariectomy and aging on the rat skeleton. Calcif Tissue Int 45: 360-366.
40. Wronski TJ, Dann LM, Horner SL (1989b) Time course of vertebral osteopenia in ovariectomized rats. Bone 10: 295-301.
41. Wronski TJ, Yen C-F, Scott KS (1991) Estrogen and diphosphonate treatment provide long-term pro-tection against osteopenia in ovariectomized rats. J Bone Miner Res 6: 387-394.
42. Yoshida S, Yamamuro T, Okumura H, Takahashi H (1991) Microstructural changes of osteopenic trabeculae in the rat. Bone 12: 185-194.
43. Zou L, Bloebaum RD, Bachus KN (1997) Reproducibility of techniques using Archimedes' principle in measuring cancellous bone volume. Med Eng Phys 19: 63-68.